Free Trial

VeriStar Capital Management LP Has $6.09 Million Holdings in Molina Healthcare, Inc. (NYSE:MOH)

Molina Healthcare logo with Medical background

VeriStar Capital Management LP increased its stake in shares of Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 7.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 20,913 shares of the company's stock after buying an additional 1,460 shares during the quarter. Molina Healthcare comprises approximately 10.2% of VeriStar Capital Management LP's holdings, making the stock its 5th largest position. VeriStar Capital Management LP's holdings in Molina Healthcare were worth $6,087,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Virtu Financial LLC acquired a new position in shares of Molina Healthcare during the third quarter worth approximately $2,111,000. Wilmington Savings Fund Society FSB bought a new stake in Molina Healthcare during the 3rd quarter valued at $113,000. Tri Ri Asset Management Corp acquired a new position in Molina Healthcare during the 3rd quarter worth $3,722,000. Oddo BHF Asset Management Sas bought a new position in shares of Molina Healthcare in the third quarter worth $2,947,000. Finally, Principal Financial Group Inc. increased its holdings in shares of Molina Healthcare by 3.3% during the third quarter. Principal Financial Group Inc. now owns 74,160 shares of the company's stock valued at $25,553,000 after purchasing an additional 2,389 shares during the period. 98.50% of the stock is owned by institutional investors and hedge funds.

Molina Healthcare Trading Down 2.4 %

MOH traded down $7.75 during trading on Thursday, reaching $319.26. The company had a trading volume of 303,034 shares, compared to its average volume of 775,996. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.62 and a current ratio of 1.62. Molina Healthcare, Inc. has a 12-month low of $262.32 and a 12-month high of $365.23. The company has a market cap of $17.30 billion, a price-to-earnings ratio of 15.63, a PEG ratio of 1.06 and a beta of 0.70. The firm's 50-day simple moving average is $321.51 and its 200 day simple moving average is $307.55.

Molina Healthcare (NYSE:MOH - Get Free Report) last released its quarterly earnings results on Wednesday, April 23rd. The company reported $6.08 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $5.96 by $0.12. Molina Healthcare had a net margin of 2.90% and a return on equity of 28.13%. The business had revenue of $11.15 billion for the quarter, compared to analyst estimates of $10.86 billion. During the same quarter in the previous year, the business earned $5.73 earnings per share. The firm's revenue was up 12.2% compared to the same quarter last year. Equities research analysts anticipate that Molina Healthcare, Inc. will post 24.4 earnings per share for the current year.

Insider Activity

In other Molina Healthcare news, Director Steven J. Orlando sold 1,000 shares of Molina Healthcare stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $301.33, for a total transaction of $301,330.00. Following the completion of the sale, the director now owns 17,375 shares of the company's stock, valued at $5,235,608.75. This trade represents a 5.44 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. 1.10% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

MOH has been the subject of a number of recent analyst reports. Sanford C. Bernstein began coverage on shares of Molina Healthcare in a research report on Tuesday, April 22nd. They issued an "outperform" rating and a $414.00 target price for the company. Robert W. Baird reiterated a "neutral" rating and issued a $375.00 price objective (up from $331.00) on shares of Molina Healthcare in a report on Tuesday, April 15th. UBS Group lowered their price objective on shares of Molina Healthcare from $374.00 to $325.00 and set a "neutral" rating on the stock in a research note on Friday, February 7th. Wells Fargo & Company upgraded Molina Healthcare from an "equal weight" rating to an "overweight" rating and upped their target price for the stock from $295.00 to $372.00 in a research report on Wednesday, March 5th. Finally, Baird R W cut Molina Healthcare from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 15th. Nine research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat, the company presently has an average rating of "Hold" and an average target price of $365.38.

Check Out Our Latest Stock Report on Molina Healthcare

About Molina Healthcare

(Free Report)

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.

Featured Stories

Institutional Ownership by Quarter for Molina Healthcare (NYSE:MOH)

Should You Invest $1,000 in Molina Healthcare Right Now?

Before you consider Molina Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.

While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in May 2025
3 Stocks Offering Rare Generational Buying Opportunities
Make Your Money Work Harder: The Power of Dividend Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines